Skip to Content

Cancers, Volume 13, Issue 16

2021 August-2 - 327 articles

Cover Story: Aptamers, which are short sequences of oligonucleotide or peptides, have become an increasingly popular tool within the field of oncology. This increase in usage is attributed to an aptamer-specific design which allows for a high degree of target specificity and high binding affinity, thus making aptamers of specific interest for the design of sensing platforms. We present the reader with all the prominent known aptamers and their receptors for the detection of breast cancer. Despite breast cancer being the most commonly occurring cancer in women worldwide, data on these aptamers are lacking and slow progress in a promising area of early detection. With the knowledge presented in this review, researchers will have a hub to explore the advantages and disadvantages of each aptamer and their target, thus allowing for informed project design and increased research in a high-priority disease. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (327)

  • Article
  • Open Access
11 Citations
4,128 Views
16 Pages

Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)

  • Bożena Katarzyna Budziszewska,
  • Aleksander Salomon-Perzyński,
  • Katarzyna Pruszczyk,
  • Joanna Barankiewicz,
  • Agnieszka Pluta,
  • Grzegorz Helbig,
  • Anna Janowska,
  • Marta Kuydowicz,
  • Łukasz Bołkun and
  • Ewa Lech-Marańda
  • + 19 authors

20 August 2021

Acute myeloid leukemia (AML) in older unfit patients is a therapeutic challenge for clinical hematologists. We evaluated the efficacy and safety of a novel low-intensity regimen consisting of low-dose cytarabine and cladribine (LD-AC+cladribine) in f...

  • Article
  • Open Access
4 Citations
3,154 Views
15 Pages

A Transcriptomic Approach Reveals Selective Ribosomal Remodelling in the Tumour Versus the Stromal Compartment of Metastatic Colorectal Cancer

  • Elena Lastraioli,
  • Federico Alessandro Ruffinatti,
  • Francesco Di Costanzo,
  • Cesare Sala,
  • Luca Munaron and
  • Annarosa Arcangeli

20 August 2021

Because of its high incidence and poor prognosis, colorectal cancer (CRC) represents an important health issue in several countries. As with other carcinomas, the so-called tumour microenvironment (TME) has been shown to play key roles in CRC progres...

  • Article
  • Open Access
7 Citations
3,445 Views
11 Pages

Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing

  • Chul Seung Lee,
  • Hoon Seok Kim,
  • Jeoffrey Schageman,
  • In Kyu Lee,
  • Myungshin Kim and
  • Yonggoo Kim

20 August 2021

The objective of this study was to characterize circulating tumor DNA (ctDNA) mutations in colorectal cancer (CRC) patients and evaluate their prognostic values during treatment. Forty-nine patients with CRC planned for operation were enrolled. A tot...

  • Review
  • Open Access
19 Citations
5,641 Views
22 Pages

Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside

  • Santa Bērziņa,
  • Alexandra Harrison,
  • Valérie Taly and
  • Wenjin Xiao

20 August 2021

Tumor-on-chip technology has cemented its importance as an in vitro tumor model for cancer research. Its ability to recapitulate different elements of the in vivo tumor microenvironment makes it promising for translational medicine, with potential ap...

  • Article
  • Open Access
40 Citations
6,903 Views
12 Pages

Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs

  • Abed Agbarya,
  • Ina Sarel,
  • Tomer Ziv-Baran,
  • Sivan Agranat,
  • Orna Schwartz,
  • Ayelet Shai,
  • Sharon Nordheimer,
  • Shlomit Fenig,
  • Yelena Shechtman and
  • Ronen Brenner
  • + 7 authors

20 August 2021

The BNT162b2 vaccine was shown to be highly effective in reducing the risk of COVID-19 infection in healthy individuals and patients with chronic disease. However, there are little data regarding its efficacy in patients treated for cancer. We analyz...

  • Article
  • Open Access
8 Citations
4,493 Views
11 Pages

Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer

  • Nicolai Mader,
  • Daniel Groener,
  • Nikolaos Tselis,
  • Séverine Banek,
  • James Nagarajah,
  • Frank Grünwald and
  • Amir Sabet

20 August 2021

The aim of this retrospective study was to assess the outcome of patients with metastasized castration-resistant early-onset prostate cancer refractory to chemotherapy receiving radioligand therapy with 177Lutetium-PSMA-617 (LuPSMA-RLT). Twenty-five...

  • Article
  • Open Access
16 Citations
4,882 Views
16 Pages

Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients

  • Ava Kwong,
  • Vivian Y. Shin,
  • Cecilia Y. S. Ho,
  • Aleena Khalid,
  • Chun Hang Au,
  • Karen K. L. Chan,
  • Hextan Y. S. Ngan,
  • Tsun-Leung Chan and
  • Edmond S. K. Ma

20 August 2021

The prevalence of the PALB2 mutation in breast cancer varies across different ethnic groups; hence, it is of intense interest to evaluate the cancer risk and clinical association of the PALB2 mutation in Chinese breast and/or ovarian cancer patients....

  • Review
  • Open Access
57 Citations
8,882 Views
15 Pages

20 August 2021

Mesothelioma is a cancer predominantly of the pleural cavity. There is a clear association of exposure to asbestos with a dose dependent risk of mesothelioma. The incidence of mesothelioma in different countries reflect the historical patterns of com...

  • Article
  • Open Access
7 Citations
4,330 Views
17 Pages

20 August 2021

During the past decade, whole-genome sequencing of tumor biopsies and individuals with congenital disorders highlighted the phenomenon of chromoanagenesis, a single chaotic event of chromosomal rearrangement. Chromoanagenesis was shown to be frequent...

  • Article
  • Open Access
59 Citations
6,857 Views
15 Pages

Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer

  • Gwen Schroyen,
  • Jeroen Blommaert,
  • Donatienne van Weehaeghe,
  • Charlotte Sleurs,
  • Mathieu Vandenbulcke,
  • Nina Dedoncker,
  • Sigrid Hatse,
  • An Goris,
  • Michel Koole and
  • Sabine Deprez
  • + 3 authors

20 August 2021

To uncover mechanisms underlying chemotherapy-induced cognitive impairment in breast cancer, we studied new biomarkers of neuroinflammation and neuronal survival. This cohort study included 74 women (47 ± 10 years) from 22 October 2017 until 20 Augus...

  • Article
  • Open Access
14 Citations
5,168 Views
20 Pages

Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment

  • Christina Bothou,
  • Ashish Sharma,
  • Adrian Oo,
  • Baek Kim,
  • Pal Perge,
  • Peter Igaz,
  • Cristina L. Ronchi,
  • Igor Shapiro and
  • Constanze Hantel

20 August 2021

Current systemic treatment options for patients with adrenocortical carcinomas (ACCs) are far from being satisfactory. DNA damage/repair mechanisms, which involve, e.g., ataxia-telangiectasia-mutated (ATM) and ataxia-telangiectasia/Rad3-related (ATR)...

  • Article
  • Open Access
9 Citations
5,395 Views
25 Pages

Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma

  • Haydee M. Torres,
  • Ashley M. VanCleave,
  • Mykayla Vollmer,
  • Dakota L. Callahan,
  • Austyn Smithback,
  • Josephine M. Conn,
  • Tania Rodezno-Antunes,
  • Zili Gao,
  • Yuxia Cao and
  • Jianning Tao
  • + 1 author

20 August 2021

Dysregulation of histone deacetylases (HDACs) is associated with the pathogenesis of human osteosarcoma, which may present an epigenetic vulnerability as well as a therapeutic target. Domatinostat (4SC-202) is a next-generation class I HDAC inhibitor...

  • Article
  • Open Access
2 Citations
3,153 Views
16 Pages

Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy

  • Rhiane Moody,
  • Kirsty Wilson,
  • Nirmala Chandralega Kampan,
  • Orla M. McNally,
  • Thomas W. Jobling,
  • Anthony Jaworowski,
  • Andrew N. Stephens and
  • Magdalena Plebanski

20 August 2021

Autoantibodies recognising phosphorylated heat shock factor 1 (HSF1-PO4) protein are suggested as potential new diagnostic biomarkers for early-stage high-grade serous ovarian cancer (HGSOC). We predicted in silico B-cell epitopes in human and murine...

  • Article
  • Open Access
33 Citations
4,679 Views
13 Pages

Raman Spectroscopy and Machine Learning for IDH Genotyping of Unprocessed Glioma Biopsies

  • Tommaso Sciortino,
  • Riccardo Secoli,
  • Ester d’Amico,
  • Sara Moccia,
  • Marco Conti Nibali,
  • Lorenzo Gay,
  • Marco Rossi,
  • Nicolò Pecco,
  • Antonella Castellano and
  • Lorenzo Bello
  • + 3 authors

20 August 2021

Isocitrate dehydrogenase (IDH) mutational status is pivotal in the management of gliomas. Patients with IDH-mutated (IDH-MUT) tumors have a better prognosis and benefit more from extended surgical resection than IDH wild-type (IDH-WT). Raman spectros...

  • Review
  • Open Access
23 Citations
5,249 Views
21 Pages

20 August 2021

Hepatocellular carcinoma (HCC) is one of the deadliest human cancers. Activating mutations in the telomerase reverse transcriptase (TERT) promoter (TERTp) and CTNNB1 gene encoding β-catenin are widespread in HCC (~50% and ~30%, respectively). TERTp m...

  • Article
  • Open Access
5 Citations
4,296 Views
15 Pages

MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer

  • Guillaume Herbreteau,
  • Fabrice Airaud,
  • Elise Pierre-Noël,
  • Audrey Vallée,
  • Stéphane Bézieau,
  • Sandrine Théoleyre,
  • Hélène Blons,
  • Simon Garinet and
  • Marc Guillaume Denis

20 August 2021

Purpose: MEM is an NGS algorithm that uses Expectation-Maximisation to detect the presence of unstable alleles from the NGS sequences of five microsatellites (BAT-25, BAT-26, NR-21, NR-24 and NR-27). The purpose of this study was to compare the MEM a...

  • Article
  • Open Access
16 Citations
3,375 Views
12 Pages

Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease

  • Naoko Okano,
  • Nobuteru Kubo,
  • Koichi Yamaguchi,
  • Shunichi Kouno,
  • Yuhei Miyasaka,
  • Tatsuji Mizukami,
  • Katsuyuki Shirai,
  • Jun-ichi Saitoh,
  • Takeshi Ebara and
  • Tatsuya Ohno
  • + 2 authors

20 August 2021

Interstitial lung disease (ILD) is a risk factor both for the development and treatment failure of lung cancer. In this retrospective study, we analyzed the outcome of carbon-ion radiotherapy (CIRT) in 124 patients with clinical stage I non-small cel...

  • Feature Paper
  • Article
  • Open Access
17 Citations
4,754 Views
13 Pages

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis

  • María Sereno,
  • Ana María Jimenez-Gordo,
  • Javier Baena-Espinar,
  • Carlos Aguado,
  • Xabier Mielgo,
  • Ana Pertejo,
  • Rosa Álvarez-Álvarez,
  • Ana Sánchez,
  • Jose Luis López and
  • Gonzalo Colmenarejo
  • + 10 authors

20 August 2021

Background: Approximately 15% of patients infected by SARS-CoV-2 develop a distress syndrome secondary to a host hyperinflammatory response induced by a cytokine storm. Myelosuppression is associated with a higher risk of infections and mortality. Th...

  • Article
  • Open Access
14 Citations
3,656 Views
14 Pages

Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms

  • Satomi Tomida,
  • Dayan B. Goodenowe,
  • Teruhide Koyama,
  • Etsuko Ozaki,
  • Nagato Kuriyama,
  • Midori Morita,
  • Yasuyo Yamazaki,
  • Koichi Sakaguchi,
  • Ritei Uehara and
  • Tetsuya Taguchi

19 August 2021

The polyunsaturated fatty acid (PUFA) elongase, ELOVL5, is upregulated in breast cancer (BC) vs. adjacent normal tissue. We performed a comprehensive lipid metabolomic analysis of serum using high-resolution accurate mass spectrometry from two case-c...

  • Article
  • Open Access
1 Citations
2,623 Views
13 Pages

Difference in Computed Tomography Image Quality between Central Vein and Peripheral Vein Enhancement in Treatment Naive Esophageal Cancer Patients

  • Chun-Bi Chang,
  • Chien-Cheng Chen,
  • Huan-Wu Chen,
  • Ching-Feng Wu,
  • Jui-Ying Fu,
  • Ming-Ju Hsieh,
  • Yang-Teng Peng,
  • Ssu-Ying Lu and
  • Ching-Yang Wu

19 August 2021

The differences in chest computed tomography (CT) image quality may affect the tumor stage. The aim of this study was to compare the image quality and accuracy of chest CT via central vein and peripheral vein enhancement. Fifty consecutive patients w...

  • Article
  • Open Access
4 Citations
2,673 Views
14 Pages

Mechanism of Differential Susceptibility of Two (Canine Lung Adenocarcinoma) Cell Lines to 5-Aminolevulinic Acid-Mediated Photodynamic Therapy

  • Tomohiro Osaki,
  • Narumi Kunisue,
  • Urara Ota,
  • Hideo Imazato,
  • Takuya Ishii,
  • Kiwamu Takahashi,
  • Masahiro Ishizuka,
  • Tohru Tanaka and
  • Yoshiharu Okamoto

19 August 2021

Photodynamic therapy (PDT) is a clinically approved, minimally invasive treatment for malignant tumors. Protoporphyrin IX (PpIX), derived from 5-aminolevulinic acid (5-ALA) as the prodrug, is one of the photosensitizers used in PDT. Recently, we repo...

  • Review
  • Open Access
16 Citations
8,475 Views
19 Pages

19 August 2021

Following the development of tyrosine kinase inhibitors (TKI), the survival of patients with chronic myeloid leukaemia (CML) drastically improved. With the introduction of these agents, CML is now considered a chronic disease for some patients. Takin...

  • Systematic Review
  • Open Access
70 Citations
9,042 Views
15 Pages

Obesity as a Risk Factor for Prostate Cancer Mortality: A Systematic Review and Dose-Response Meta-Analysis of 280,199 Patients

  • Mario Rivera-Izquierdo,
  • Javier Pérez de Rojas,
  • Virginia Martínez-Ruiz,
  • Beatriz Pérez-Gómez,
  • María-José Sánchez,
  • Khalid Saeed Khan and
  • José Juan Jiménez-Moleón

19 August 2021

The aim of this study was to systematically review all evidence evaluating obesity as a prognostic factor for PC mortality. Cohort and case-control studies reporting mortality among PC patients stratified by body mass index (BMI) were included. The r...

  • Article
  • Open Access
9 Citations
4,744 Views
18 Pages

Small Extracellular Vesicles from Head and Neck Squamous Cell Carcinoma Cells Carry a Proteomic Signature for Tumor Hypoxia

  • Alicja Głuszko,
  • Mirosław J. Szczepański,
  • Theresa L. Whiteside,
  • Torsten E. Reichert,
  • Jacek Siewiera and
  • Nils Ludwig

19 August 2021

Tissue hypoxia is commonly observed in head and neck squamous cell carcinomas (HNSCCs), resulting in molecular and functional alterations of the tumor cells. The aim of this study was to characterize tumor-derived small extracellular vesicles (sEVs)...

  • Review
  • Open Access
20 Citations
5,816 Views
32 Pages

19 August 2021

Pancreatic ductal adenocarcinoma (PDAC), the most common malignancy of the pancreas, shows a dismal and grim overall prognosis and survival rate, which have remained virtually unchanged for over half a century. PDAC is the most lethal of all cancers,...

  • Feature Paper
  • Article
  • Open Access
22 Citations
4,368 Views
20 Pages

Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice

  • Pi-Shan Sung,
  • Pei-Wen Chen,
  • Chia-Jui Yen,
  • Meng-Ru Shen,
  • Chih-Hung Chen,
  • Kuen-Jer Tsai and
  • Chou-Ching K. Lin

19 August 2021

Chemotherapy-induced cognitive impairment (CICI) is an adverse side effect of cancer treatment with increasing awareness. Hippocampal damage and related neurocognitive impairment may mediate the development of CICI, in which altered neurogenesis may...

  • Review
  • Open Access
25 Citations
6,087 Views
21 Pages

Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology

  • Andrzej Nowicki,
  • Magdalena Kulus,
  • Maria Wieczorkiewicz,
  • Wojciech Pieńkowski,
  • Katarzyna Stefańska,
  • Paulina Skupin-Mrugalska,
  • Rut Bryl,
  • Paul Mozdziak,
  • Bartosz Kempisty and
  • Hanna Piotrowska-Kempisty

19 August 2021

Despite the increasing development of medicine, ovarian cancer is still a high-risk, metastatic disease that is often diagnosed at a late stage. In addition, difficulties in its treatment are associated with high resistance to chemotherapy and freque...

  • Article
  • Open Access
10 Citations
4,600 Views
17 Pages

Integrative Metabolomic and Lipidomic Profiling of Lung Squamous Cell Carcinoma for Characterization of Metabolites and Intact Lipid Species Related to the Metastatic Potential

  • Heayyean Lee,
  • Hwanhui Lee,
  • Sujeong Park,
  • Myeongsun Kim,
  • Ji Young Park,
  • Hanyong Jin,
  • Kyungsoo Oh,
  • Jeehyeon Bae,
  • Young Yang and
  • Hyung-Kyoon Choi

19 August 2021

SQCC is a major type of NSCLC, which is a major cause of cancer-related deaths, and there were no reports regarding the prediction of metastatic potential of lung SQCC by metabolomic and lipidomic profiling. In this study, metabolomic and lipidomic p...

  • Article
  • Open Access
12 Citations
3,445 Views
16 Pages

SARAF and EFHB Modulate Store-Operated Ca2+ Entry and Are Required for Cell Proliferation, Migration and Viability in Breast Cancer Cells

  • Isaac Jardin,
  • Joel Nieto-Felipe,
  • Sandra Alvarado,
  • Raquel Diez-Bello,
  • Jose J. Lopez,
  • Ginés M. Salido,
  • Tarik Smani and
  • Juan A. Rosado

19 August 2021

Breast cancer is among the most common malignancies in women. From the molecular point of view, breast cancer can be grouped into different categories, including the luminal (estrogen receptor positive (ER+)) and triple negative subtypes, which show...

  • Review
  • Open Access
28 Citations
4,881 Views
24 Pages

Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs

  • Yiwei Li,
  • Mohammed Najeeb Al Hallak,
  • Philip A. Philip,
  • Asfar S. Azmi and
  • Ramzi M. Mohammad

19 August 2021

Pancreatic cancer is an aggressive malignance with high mortality. The lack of early diagnosis and effective therapy contributes to the high mortality of this deadly disease. For a long time being, the alterations in coding RNAs have been considered...

  • Article
  • Open Access
7 Citations
4,372 Views
11 Pages

Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy

  • Shirin Moghaddam,
  • Amirhossein Jalali,
  • Amanda O’Neill,
  • Lisa Murphy,
  • Laura Gorman,
  • Anne-Marie Reilly,
  • Áine Heffernan,
  • Thomas Lynch,
  • Richard Power and
  • R. William Watson
  • + 6 authors

19 August 2021

This study undertook to predict biochemical recurrence (BCR) in prostate cancer patients after radical prostatectomy using serum biomarkers and clinical features. Three radical prostatectomy cohorts were used to build and validate a model of clinical...

  • Article
  • Open Access
8 Citations
4,719 Views
13 Pages

Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience

  • Samitha Andrahennadi,
  • Amer Sami,
  • Kamal Haider,
  • Haji Ibraheem Chalchal,
  • Duc Le,
  • Osama Ahmed,
  • Mita Manna,
  • Ali El-Gayed,
  • Philip Wright and
  • Shahid Ahmed

19 August 2021

Introduction: Fulvestrant has demonstrated efficacy in hormone receptor positive (HR+) metastatic breast cancer (mBC), both in first-and second-line settings. In clinical practice, however, fulvestrant has been used as a later-line therapy. This stud...

  • Article
  • Open Access
10 Citations
4,639 Views
20 Pages

Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy

  • Gabriele Madonna,
  • Giuseppe V. Masucci,
  • Mariaelena Capone,
  • Domenico Mallardo,
  • Antonio Maria Grimaldi,
  • Ester Simeone,
  • Vito Vanella,
  • Lucia Festino,
  • Marco Palla and
  • Paolo Antonio Ascierto
  • + 8 authors

19 August 2021

The real-life application of immune checkpoint inhibitors (ICIs) may yield different outcomes compared to the benefit presented in clinical trials. For this reason, there is a need to define the group of patients that may benefit from treatment. We r...

  • Article
  • Open Access
11 Citations
5,198 Views
18 Pages

Measuring NQO1 Bioactivation Using [2H7]Glucose

  • Rohit Mahar,
  • Mario C. Chang and
  • Matthew E. Merritt

19 August 2021

Treatment of cancers with β-lapachone causes NAD(P)H: quinone oxidoreductase 1 (NQO1) to generate an unstable hydroquinone that regenerates itself in a futile cycle while producing reactive oxygen species (ROS) in the form of superoxide and subsequen...

  • Systematic Review
  • Open Access
97 Citations
6,500 Views
20 Pages

Prognostic Utility of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio and Monocyte–Lymphocyte Ratio in Head and Neck Cancers: A Detailed PRISMA Compliant Systematic Review and Meta-Analysis

  • Chellan Kumarasamy,
  • Vaibhav Tiwary,
  • Krishnan Sunil,
  • Deepa Suresh,
  • Sameep Shetty,
  • Gothandam Kodiveri Muthukaliannan,
  • Siddhartha Baxi and
  • Rama Jayaraj

19 August 2021

Inflammation plays a major role in cancer development and progression and has the potential to be used as a prognostic marker in cancer. Previous studies have attempted to evaluate Platelet-to-lymphocyte ratio (PLR), neutrophil–lymphocyte ratio (NLR)...

  • Review
  • Open Access
12 Citations
5,479 Views
18 Pages

Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer

  • Vijayashree Murthy,
  • Jessica Young,
  • Yoshihisa Tokumaru,
  • Marie Quinn,
  • Stephen B. Edge and
  • Kazuaki Takabe

19 August 2021

Increasing use of neoadjuvant therapy in large tumors or node positive disease in breast cancer patients or hormone negative and HER 2 overexpressing cancers often gives rise to complete clinical response, with resolution of disease in the breast and...

  • Article
  • Open Access
12 Citations
5,446 Views
27 Pages

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

  • Joaquim Bosch-Barrera,
  • Sara Verdura,
  • José Carlos Ruffinelli,
  • Enric Carcereny,
  • Elia Sais,
  • Elisabet Cuyàs,
  • Ramon Palmero,
  • Eugeni Lopez-Bonet,
  • Alejandro Hernández-Martínez and
  • Javier A. Menendez
  • + 5 authors

19 August 2021

The anti-angiogenic agent nintedanib has been shown to prolong overall and progression-free survival in patients with advanced non-small-cell lung cancer (NSCLC) who progress after first-line platinum-based chemotherapy and second-line immunotherapy....

  • Review
  • Open Access
25 Citations
10,791 Views
20 Pages

TYK2 in Cancer Metastases: Genomic and Proteomic Discovery

  • Dana C. Borcherding,
  • Kevin He,
  • Neha V. Amin and
  • Angela C. Hirbe

19 August 2021

Advances in genomic analysis and proteomic tools have rapidly expanded identification of biomarkers and molecular targets important to cancer development and metastasis. On an individual basis, personalized medicine approaches allow better characteri...

  • Conference Report
  • Open Access
1 Citations
2,998 Views
12 Pages

Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology—Highlights of the 8th Heidelberg Myeloma Workshop

  • Raphael Lutz,
  • Mirco Friedrich,
  • Marc Steffen Raab,
  • Niels Weinhold and
  • Hartmut Goldschmidt

18 August 2021

The diagnostics and treatment of newly diagnosed and relapsed MM are continuously evolving. While advances in the field of (single cell) genetic analysis now allow for characterization of the disease at an unprecedented resolution, immunotherapeutic...

  • Review
  • Open Access
13 Citations
6,264 Views
18 Pages

The Mutational Landscape of Myeloid Leukaemia in Down Syndrome

  • Carini Picardi Morais de Castro,
  • Maria Cadefau and
  • Sergi Cuartero

18 August 2021

Children with Down syndrome (DS) are particularly prone to haematopoietic disorders. Paediatric myeloid malignancies in DS occur at an unusually high frequency and generally follow a well-defined stepwise clinical evolution. First, the acquisition of...

  • Review
  • Open Access
26 Citations
4,515 Views
21 Pages

Modulation of Cancer Cell Autophagic Responses by Graphene-Based Nanomaterials: Molecular Mechanisms and Therapeutic Implications

  • Biljana Ristic,
  • Ljubica Harhaji-Trajkovic,
  • Mihajlo Bosnjak,
  • Ivana Dakic,
  • Srdjan Mijatovic and
  • Vladimir Trajkovic

18 August 2021

Graphene-based nanomaterials (GNM) are plausible candidates for cancer therapeutics and drug delivery systems. Pure graphene and graphene oxide nanoparticles, as well as graphene quantum dots and graphene nanofibers, were all able to trigger autophag...

  • Article
  • Open Access
10 Citations
2,942 Views
13 Pages

Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma

  • Zahra Souri,
  • Aart G. Jochemsen,
  • Annemijn P. A. Wierenga,
  • Wilma G. M. Kroes,
  • Rob M. Verdijk,
  • Pieter A. van der Velden,
  • Gregorius P. M. Luyten and
  • Martine J. Jager

18 August 2021

In Uveal Melanoma (UM), an inflammatory phenotype is strongly associated with the development of metastases and with chromosome 3/BAP1 expression loss. As an increased expression of several Histone Deacetylases (HDACs) was associated with loss of chr...

  • Article
  • Open Access
14 Citations
4,736 Views
14 Pages

Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

  • Martine Berliere,
  • Nathan Piette,
  • Marion Bernard,
  • Camille Lacroix,
  • Amandine Gerday,
  • Vasiliki Samartzi,
  • Maude Coyette,
  • Fabienne Roelants,
  • Marie-Agnes Docquier and
  • Fran×ois P. Duhoux
  • + 3 authors

18 August 2021

Background: Reducing side effects of cancer treatments is a major challenge for clinicians involved in the management of breast cancer patients. Methods: We analyzed data from 63 patients (32 in the general anesthesia group and 31 in the hypnosis sed...

  • Review
  • Open Access
41 Citations
7,116 Views
23 Pages

18 August 2021

Implementing risk-stratified breast cancer screening is being considered internationally. It has been suggested that primary care will need to take a role in delivering this service, including risk assessment and provision of primary prevention advic...

  • Article
  • Open Access
16 Citations
3,960 Views
18 Pages

Serum DJ-1 Is a Biomarker of Colorectal Cancer and DJ-1 Activates Mitophagy to Promote Colorectal Cancer Progression

  • William Tzu-Liang Chen,
  • Han-Bin Yang,
  • Tao-Wei Ke,
  • Wen-Ling Liao and
  • Shih-Ya Hung

18 August 2021

Colorectal cancer is the second most common cancer and the third cancer-associated death in Taiwan. Currently used serum markers for detecting colorectal cancer lack excellent diagnostic accuracy, which results in colorectal cancer being often recogn...

  • Article
  • Open Access
25 Citations
3,382 Views
13 Pages

HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study

  • Antoine Baumann,
  • Julie Henriques,
  • Zohair Selmani,
  • Aurélia Meurisse,
  • Quentin Lepiller,
  • Dewi Vernerey,
  • Séverine Valmary-Degano,
  • Sophie Paget-Bailly,
  • Didier Riethmuller and
  • Jean-Luc Prétet
  • + 2 authors

18 August 2021

High-risk HPV (hrHPV) testing has been implemented as a primary screening tool for cervical cancer in numerous countries. However, there is still a need for relevant triage strategies to manage hrHPV positive women to avoid excessive referral to colp...

  • Article
  • Open Access
38 Citations
7,787 Views
21 Pages

PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells

  • Iga Jancewicz,
  • Joanna Szarkowska,
  • Ryszard Konopinski,
  • Malgorzata Stachowiak,
  • Monika Swiatek,
  • Katarzyna Blachnio,
  • Szymon Kubala,
  • Paulina Oksinska,
  • Pawel Cwiek and
  • Elzbieta A. Sarnowska
  • + 12 authors

18 August 2021

Growing tumors avoid recognition and destruction by the immune system. During continuous stimulation of tumor-infiltrating lymphocytes (TILs) by tumors, TILs become functionally exhausted; thus, they become unable to kill tumor cells and to produce c...

  • Article
  • Open Access
16 Citations
5,023 Views
33 Pages

Pan-Cancer Analysis of Prognostic and Immune Infiltrates for CXCs

  • Long Li,
  • Wenchao Yao,
  • Sen Yan,
  • Xianghui Dong,
  • Zhenyi Lv,
  • Qingxu Jing,
  • Qiang Wang,
  • Biao Ma,
  • Chenjun Hao and
  • Dawei Wang
  • + 1 author

18 August 2021

Background: CXCs are important genes that regulate inflammation and tumor metastasis. However, the expression level, prognosis value, and immune infiltration of CXCs in cancers are not clear. Methods: Multiple online datasets were used to analyze the...

  • Review
  • Open Access
19 Citations
6,699 Views
15 Pages

The Role of Positron Emission Tomography/Computed Tomography (PET/CT) for Staging and Disease Response Assessment in Localized and Locally Advanced Pancreatic Cancer

  • Michele Ghidini,
  • Marta Vuozzo,
  • Barbara Galassi,
  • Paola Mapelli,
  • Virginia Ceccarossi,
  • Lucio Caccamo,
  • Maria Picchio and
  • Daniele Dondossola

18 August 2021

Pancreatic Cancer (PC) has a poor prognosis, with a 5-year survival rate of only 9%. Even after radical surgical procedures, PC patients have poor survival rates, with a high chance of relapse (70–80%). Imaging is involved in all aspects of the clini...

  • Article
  • Open Access
8 Citations
3,422 Views
15 Pages

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

  • Melissa Frizziero,
  • Alice Durand,
  • Rodrigo G. Taboada,
  • Elisa Zaninotto,
  • Claudio Luchini,
  • Bipasha Chakrabarty,
  • Valérie Hervieu,
  • Laura C. L. Claro,
  • Cong Zhou and
  • Mairéad G. McNamara
  • + 8 authors

18 August 2021

Extra-pulmonary neuroendocrine carcinomas (EP-NECs) are lethal cancers with limited treatment options. Identification of contributing factors to the observed heterogeneity of clinical outcomes within the EP-NEC family is warranted, to enable identifi...

of 7

XFacebookLinkedIn
Cancers - ISSN 2072-6694